14 results
10-Q
2020 Q1
BEAM
Beam Therapeutics Inc
12 May 20
Quarterly report
4:14pm
results of operations and cause reputational damage. Some of the raw materials that we anticipate will be required in our manufacturing process … are derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination or recall. A material shortage
10-K
ekomsge
30 Mar 20
Annual report
5:26pm
424B4
v25 rhv0ssslb
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
6ttuzdwxwfyld
17 Jan 20
IPO registration (amended)
4:09pm
S-1
kei9k1r
27 Sep 19
IPO registration
4:34pm
DRS/A
nm5wek
9 Sep 19
Draft registration statement (amended)
12:00am
DRS
37m35ksz8
29 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next